HIPAA Alert: Potential Data Breach Learn More

Close this search box.

Moutaz Ghrewati, MD

Board Certifications: Advanced Cardiac Life Support, Internal Medicine and Medical Doctor

Specializations: Hematology and Medical Oncology

Languages: Arabic, English, Spanish and Turkish

Locations: Hackensack, NJ

Throughout his career, Dr. Ghrewati has worked to create nurturing relationships with his patients, regardless of cultural, ethnic and socioeconomic backgrounds, while building strong partnerships with health care professionals. He promotes individual-centered care with an interest in bone marrow and cellular therapy and applies an up-to-date awareness of national care management trends while exhibiting astute knowledge and professionalism.


Medical Education

  • University of Kalamoon — Faculty of Medicine, Syrian Arab Republic

  • St. Joseph’s Regional Medical Center, Paterson, New Jersey


  • St. Joseph’s Regional Medical Center, Paterson, New Jersey, Internal Medicine


  • St. Joseph’s Wayne Hospital, Wayne, New Jersey, Internal Medicine


  • St. Joseph’s Regional Medical Center, Paterson, New Jersey, Hematology/Oncology


Awards and honors


  • Resident Gold Humanism Honor Society (GHHS) Award – NYMC (June 2020)
  • Top 10 Students of Medicine (2007 – 2014) / Top 3 Highest In-Service Exam Score (2018)


  • American Medical Association
  • American Society of Hematology
  • Syrian American Medical Society
  • American Society of Clinical Oncology
  • American Society of Transplant and Cellular Therapy


  • Joseph’s University Medical center 
  • St. Joseph’s Wayne General Hospital
  • Hackensack University Medical Center

we are here for you

For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.

Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.